Jingqin (Rosy) Luo, PhD

Jingqin (Rosy) Luo, PhD

Primary Academic Title

Associate Professor of Surgery, Division of Public Health Sciences, Washington University School of Medicine

Research Interest

Statistical analysis of microarray gene expression data and proteomics data, ranging from power calculation to biomarker identification and patient classification.


  • 2001: MS, statistics, Renmin University, Beijing
  • 2004: MS, statistics, Duke University, Durham, N.C.
  • 2006: PhD, statistics, Duke University

Selected Research Publications

Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy.
  • Kudruk S, Forsyth CM, Dion MZ, [...] Luo J, [...] Artzi N
  • Proc Natl Acad Sci USA 2024
Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer.
  • James CA, Baer JM, Zou C, [...] Luo J, [...] DeNardo DG
  • Cancer Immunol Res 2023
Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer.
  • Nguyen T, Sridaran D, Chouhan S, [...] Luo J, [...] Mahajan NP
  • Nat Commun 2023
TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma.
  • Sun R, Han R, McCornack C, [...] Luo J, [...] Kim AH
  • Sci Adv 2023
Clonal Hematopoiesis and Risk of Incident Lung Cancer.
  • Tian R, Wiley B, Liu J, [...] Luo J, [...] Cao Y
  • J Clin Oncol 2023
CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses.
  • He M, Roussak K, Ma F, [...] Luo J, [...] Klechevsky E
  • Science 2023
Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting.
  • Sawant M, Mahajan K, Renganathan A, [...] Luo J, [...] Mahajan NP
  • Sci Transl Med 2022
Loss of Long Noncoding RNA NXTAR in Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide Resistance.
  • Ghildiyal R, Sawant M, Renganathan A, [...] Luo J, [...] Mahajan NP
  • Cancer Res 2022

View All Publications